326 - 350 of 8808 Results
Title
Year
-
RESTRICTEDTitle: Nano drug delivery systems for antisense oligonucleotides (ASO) therapeuticsJournal Name: Journal of Controlled ReleasePublisher: Elsevier BVVol: 352Issue #:Start Page: 861End Page: 878Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jconrel.2022.10.050Citation Count: 34
-
RESTRICTEDTitle: Autophagy in hepatic adaptation to stressJournal Name: Journal of HepatologyPublisher: Elsevier BVVol: 72Issue #: 1Start Page: 183End Page: 196Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.jhep.2019.08.026Best OA location URL: http://manuscript.elsevier.com/S0168827819305203/pdf/S0168827819305203.pdfCitation Count: 124
-
RESTRICTEDTitle: From Lysosomal Storage Disorders to Parkinson’s Disease – Challenges and OpportunitiesJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 435Issue #: 12Start Page: 167932End Page: 167932Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.jmb.2022.167932Best OA location URL: https://doi.org/10.1016/j.jmb.2022.167932Citation Count: 9
-
RESTRICTEDTitle: Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic reviewJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 415Issue #:Start Page: 116886End Page: 116886Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2020.116886Best OA location URL: https://discovery.ucl.ac.uk/10102806/1/Rizig_Revised%20MS%20-%20Clean%20Version.pdfCitation Count: 16
-
RESTRICTEDTitle: Functional neurological disorder and somatic symptom disorder in Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 433Issue #:Start Page: 120017End Page: 120017Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2021.120017Citation Count: 12
-
RESTRICTEDTitle: Parkinsonism and tremor syndromesJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 433Issue #:Start Page: 120018End Page: 120018Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2021.120018Best OA location URL: http://www.jns-journal.com/article/S0022510X21027143/pdfCitation Count: 12
-
RESTRICTEDTitle: Improving functional disability in patients with tremor: A clinical perspective of the efficacies, considerations, and challenges of assistive technologyJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 435Issue #:Start Page: 120197End Page: 120197Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2022.120197Best OA location URL: http://www.jns-journal.com/article/S0022510X22000594/pdfCitation Count: 13
- How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative review2021RESTRICTEDTitle: How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative reviewJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00160-3Best OA location URL: https://www.nature.com/articles/s41531-021-00160-3.pdfCitation Count: 59
-
RESTRICTEDTitle: LRRK2 signaling in neurodegeneration: two decades of progressJournal Name: Essays in BiochemistryPublisher: Portland Press Ltd.Vol: 65Issue #: 7Start Page: 859End Page: 872Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1042/ebc20210013Citation Count: 10
- Modelling the functional genomics of Parkinson’s disease inCaenorhabditis elegans:LRRK2and beyond2021RESTRICTEDTitle: Modelling the functional genomics of Parkinson’s disease inCaenorhabditis elegans:LRRK2and beyondJournal Name: Bioscience ReportsPublisher: Portland Press Ltd.Vol: 41Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/bsr20203672Best OA location URL: https://portlandpress.com/bioscirep/article-pdf/41/9/BSR20203672/920054/bsr-2020-3672c.pdfCitation Count: 9
- Chronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal Dementia2020RESTRICTEDTitle: Chronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal DementiaJournal Name: Seminars in NeurologyPublisher: Georg Thieme Verlag KGVol: 40Issue #: 04Start Page: 394End Page: 410Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/s-0040-1715134Citation Count: 8
-
RESTRICTEDTitle: Allosteric inhibition of LRRK2, where are we nowJournal Name: Biochemical Society TransactionsPublisher: Portland Press Ltd.Vol: 48Issue #: 5Start Page: 2185End Page: 2194Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1042/bst20200424Best OA location URL: https://portlandpress.com/biochemsoctrans/article-pdf/48/5/2185/896516/bst-2020-0424c.pdfCitation Count: 10
- Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease2021RESTRICTEDTitle: Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's DiseaseJournal Name: Seminars in Thrombosis and HemostasisPublisher: Georg Thieme Verlag KGVol: 48Issue #: 03Start Page: 382End Page: 404Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/s-0041-1733960Citation Count: 5
-
RESTRICTEDTitle: On demand therapy for Parkinson’s disease patients: Opportunities and choicesJournal Name: Postgraduate MedicinePublisher: Informa UK LimitedVol: 133Issue #: 7Start Page: 721End Page: 727Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/00325481.2021.1936087Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/00325481.2021.1936087?needAccess=trueCitation Count: 16
- Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration2021RESTRICTEDTitle: Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titrationJournal Name: Postgraduate MedicinePublisher: Informa UK LimitedVol: 133Issue #: 1Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/00325481.2020.1857992Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/00325481.2020.1857992?needAccess=trueCitation Count: 10
-
RESTRICTEDTitle: A systematic review of group intervention for acquired dysarthria in adultsJournal Name: Disability and RehabilitationPublisher: Informa UK LimitedVol: 44Issue #: 13Start Page: 3002End Page: 3018Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/09638288.2020.1859629Citation Count: 9
-
RESTRICTEDTitle: Targeting mitophagy in Parkinson's diseaseJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 296Issue #:Start Page: 100209End Page: 100209Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.rev120.014294Best OA location URL: https://doi.org/10.1074/jbc.rev120.014294Citation Count: 72
-
RESTRICTEDTitle: Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an updateJournal Name: Expert Opinion on Emerging DrugsPublisher: Informa UK LimitedVol: 25Issue #: 2Start Page: 131End Page: 144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14728214.2020.1763954Citation Count: 13
-
RESTRICTEDTitle: Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practiceJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 20Issue #: 5Start Page: 477End Page: 495Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1752669Citation Count: 29
-
RESTRICTEDTitle: Therapeutic innovation in Parkinson’s disease: a 2020 update on disease-modifying approachesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 20Issue #: 10Start Page: 1047End Page: 1064Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1800454Citation Count: 12
-
RESTRICTEDTitle: The necroptosis pathway and its role in age-related neurodegenerative diseases: will it open up new therapeutic avenues in the next decade?Journal Name: Expert Opinion on Therapeutic TargetsPublisher: Informa UK LimitedVol: 24Issue #: 7Start Page: 679End Page: 693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14728222.2020.1758668Citation Count: 14
-
RESTRICTEDTitle: A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson’s disease ‘OFF’ episodesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 21Issue #: 2Start Page: 169End Page: 177Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1855145Citation Count: 9
- Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone2021RESTRICTEDTitle: Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicaponeJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 21Issue #: 9Start Page: 1019End Page: 1033Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/14737175.2021.1968298Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/14737175.2021.1968298?needAccess=trueCitation Count: 20
- Noninvasive vagus nerve stimulation in Parkinson’s disease: current status and future prospects2021RESTRICTEDTitle: Noninvasive vagus nerve stimulation in Parkinson’s disease: current status and future prospectsJournal Name: Expert Review of Medical DevicesPublisher: Informa UK LimitedVol: 18Issue #: 10Start Page: 971End Page: 984Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1080/17434440.2021.1969913Best OA location URL: https://doi.org/10.1080/17434440.2021.1969913Citation Count: 17
-
RESTRICTEDTitle: Hallucinations and delusions associated with Parkinson’s disease psychosis: safety of current treatments and future directionsJournal Name: Expert Opinion on Drug SafetyPublisher: Informa UK LimitedVol: 21Issue #: 7Start Page: 873End Page: 879Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/14740338.2022.2069240Best OA location URL: https://doi.org/10.1080/14740338.2022.2069240Citation Count: 8